Navigation Links
New Form of Painkiller May Fight Colon Cancer
Date:4/21/2010

Lab tests suggest that variation of naproxen might nip cancer in the bud, expert says,,

WEDNESDAY, April 21 (HealthDay News) -- Adding to previous research suggesting that painkillers can reduce the risk for colon cancer, researchers report that an investigational form of the drug naproxen blocks a molecular process that leads to the disease.

Commonly known by such brand names as Aleve, Anaprox and Naprosyn, the standard form of naproxen is a generic pain medication.

Though the drug has been tested only in the laboratory, not on people, "it appears that the investigational form of naproxen we studied may be more effective than standard naproxen in inhibiting colorectal tumor development," Margie Clapper, co-leader of the Cancer Prevention and Control Program at Fox Chase Cancer Center, said in a news release from the center. "An added benefit would be the reduced gastrointestinal toxicity of this novel type of naproxen."

Researchers found that the new type of naproxen, known as NO-naproxen, appeared to block a signaling pathway that plays a role in the formation of colorectal cancer.

Based on laboratory data, "we think that NO-naproxen is much better than naproxen in nipping this whole process in the bud," Clapper said.

The scientists are testing their finding in mice but do not yet have the results.

The study findings were scheduled to be released at the annual meeting of the American Association for Cancer Research, April 17 to 21 in Washington D.C.

More information

The American Cancer Society has more about colon cancer.



-- Randy Dotinga



SOURCE: Fox Chase Cancer Center, news release, April 21, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Page: 1

Related medicine news :

1. Another perk of painkillers? Decreased hormone levels may reduce cancer risk
2. Painkillers Lower Estrogen Levels, May Explain Cancer Reduction Risk
3. Overdoses From Prescription Painkillers on the Rise
4. Makers of Powerful Painkillers Present Safety Plans
5. San Francisco Firefighters: Increased Risk for Bladder Cancer – Testing Underway
6. Firefighters Walk Over 60,000 Miles in Blue Cross Blue Shield of Massachusetts' Fitness Challenge
7. Hormone Therapy May Fight Resistant Prostate Cancer
8. Registration Now Open for Little Red Door's Unite 2 Fight Race Against Prostate Cancer Saturday, July 10, 2010
9. Author Erin Morrow Still Releases "Fighting MS: Strength in Numbers"
10. Scientists Find Clues to How the Body Fights Off HIV
11. Sokolove Law Helps Thousands of Consumers Fight Unfair Disability Insurance Denial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... As health professionals work to improve ... engagement.” The patient is doing more than filling out a survey; in many cases ... an increasing emphasis in health care and research on the importance of active engagement ...
(Date:10/13/2017)... Nevada (PRWEB) , ... October 13, 2017 , ... ... Hemp CBD Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil ... required and providing a CBD form that can be easily incorporated into liquid products, ...
(Date:10/13/2017)... OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... or dementia. However, many long-term care insurance companies have a waiver for care if ... the 90-day elimination period, when the family pays for care, is often waived, so ...
(Date:10/13/2017)... ... ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has released a ... books in the Holy Scriptures, Revelation. The Book of Revelation paints a picture of ... have tossed it off as mere rubbish, but Yisrayl Hawkins says that is because ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian history ... The Brink” is the creation of published author, William Nowers. Captain Nowers and ... WWII veteran, he spent thirty years in the Navy. Following his career as ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a leading global digital ... its MyDario product is expected to appear on The Dr. Oz Show ... Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. Oz Show kicked off ... The segment features ...
(Date:9/23/2017)... -- Janssen Biotech, Inc. (Janssen) announced today that it ... Food and Drug Administration (FDA) for the Biologics License ... of moderately to severely active rheumatoid arthritis (RA). The ... to further evaluate the safety of sirukumab in the ... "We are disappointed by ...
(Date:9/19/2017)... , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing ... of targeted tissues, announced three leadership team developments today:   ... ... ... Veteran medical device executive Josh Stopek ...
Breaking Medicine Technology: